CDKN2B-AS1 and brain ischemia: Down-regulation of ANRIL may attenuate acute cerebral ischemia-reperfusion-induced injury and neuroinflammation by regulating the miR-671-5p/NF-κB signaling pathway, suggesting that ANRIL may be a potential target for the treatment of ischemic stroke.